Albany, New York, June 5, 2017: Market Research Hub’s announced a report on Nanomix Inc Product Pipeline Analysis. This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1107620
Nanomix Inc (R&D Ab) is a provider of antibodies, immunoassays, and assay kits. The company offers products such as RIA kits, IFA kits, monoclonal antibodies and polyclonal antisera for ELISA, immunocytochemistry, western blotting, immunoprecipitation, and RIA. Its antibodies include monoclonal, histochemical grade, immunoprecipitating antibodies, BoTox and BoTox substrate antibodies and kits, dopamine receptor, leptin, muscarinic receptor, nicotinic receptor, nitric oxide synthase antibodies and kits, opioid receptor, slurp receptor, thrombopoietin antibodies and kits. R&D Abs offers immunofluorescent assay kits, and western reagents. Its services include monoclonal antibody development and production, immunoassay development services, ELISA characterization of antibodies, conjugation of peptides, haptens and enzymes antibody purification. R&D Ab is headquartered in Las Vegas, Nevada, the US.
Scope:
– The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
– The report analyzes all pipeline products in development for the company Nanomix Inc
– The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
– The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
– The report provides detailed description of products in development, technical specification and functions
– The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
– Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
– Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
– To formulate effective Research & Development strategies
– Develop market-entry and market expansion strategies
– Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
– Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
– Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Browse Full Report with TOC @ http://www.marketresearchhub.com/report/nanomix-inc-product-pipeline-analysis-2017-update-report.html
Table of Contents:
Table of Contents 2
List of Tables 3
List of Figures 3
Nanomix Inc Company Overview 4
Nanomix Inc Company Snapshot 4
Nanomix Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Nanomix Inc Pipeline Analysis Overview 7
Nanomix Inc – Key Facts 7
Nanomix Inc – Major Products and Services 8
Nanomix Inc Pipeline Products by Development Stage 9
Nanomix Inc Pipeline Products Overview 11
CapLite 11
CapLite Product Overview 11
Nanomix Asthma Management System 12
Nanomix Asthma Management System Product Overview 12
Nanomix eLab – Sepsis Panel 13
Nanomix eLab – Sepsis Panel Product Overview 13
Nanomix System – Ebola Virus 14
Nanomix System – Ebola Virus Product Overview 14
Omega-3 Cardiac Panel 15
Omega-3 Cardiac Panel Product Overview 15
Nanomix Inc – Key Competitors 16
Nanomix Inc – Key Employees 17
Nanomix Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Nanomix Inc, Recent Developments 19
Mar 07, 2017: Nanomix Awarded U.S. Patent for Nanoelectronic Electrochemical Test Device 19
Dec 13, 2016: Nanomix Advances Rapid Diagnostic Panel to Aid Emergency Evaluation of Sepsis 19
Nov 25, 2014: Nanomix Receives ISO 13485:2003 Certification 20
Nov 17, 2014: Nanomix Appoints Dr. Tom Richards as Senior Advisor 20
Mar 17, 2014: Nanomix Awarded Design Patent in Japan for Point of Care Cartridge 20
Mar 18, 2013: Nanomix Receives US Patent For Carbon Nanotube Sensor Technology 20
Feb 11, 2013: Nanomix Initiates Clinical Testing Of Point Of Care IVD Cardiac Panel 21
Oct 30, 2012: Nanomix awarded NASA development subcontract 21
Appendix 22
Methodology 22
About GlobalData 24
Contact Us 24
Disclaimer 24
About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of Research Reports and analysis. MRH’s expansive collection of medical Equipment research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Read More Industry News @ https://www.industrynewsanalysis.com/